Oruka Therapeutics, Inc. (ORKA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Oruka Therapeutics, Inc. (ORKA).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $13.67

Daily Change: -$0.52 / 3.80%

Daily Range: $13.49 - $14.54

Market Cap: $511,811,648

Daily Volume: 99,043

Performance Metrics

1 Week: 0.59%

1 Month: -3.94%

3 Months: 43.29%

6 Months: -4.34%

1 Year: -26.96%

YTD: -29.50%

Company Details

Employees: 28

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Selected stocks

abrdn Income Credit Strategies Fund (ACP)

MV Oil Trust (MVO)

VOC Energy Trust (VOC)